Credit: Canva
Whether you're lifting heavy weights at the gym or sitting for long hours at your desk, a strong set of glutes is essential for overall health and functionality. Gluteus maximus—the largest muscle in the body—plays a crucial role in supporting your spine and assisting in movements like walking, running, and jumping. Now, when you think about this muscle, you think about complex exercises like deadlifts or kettlebell swings, however one simple yet effective move you can do anywhere is the glute bridges.
The glute bridge is an easy exercise which is accessible to anyone, regardless of skill level and can be performed anywhere. It can be done at the gym, on the floor at home, or even at the office. Fitness experts call it a versatile exercise that activates not only your glutes but also your hamstrings and core. Moreover, it is an excellent warm-up for experienced lifters before heavy training.
While this exercise primarily targets the glutes, it also engages the hamstrings and core, helping to stabilize the body and improve posture. It is pertinent to note that a strong core is pivotal to performing daily activities.
2. Squeeze your core to create tension, and think about pulling your shoulder blades down toward your hips.
3. Lift your hips toward the ceiling by squeezing your glutes and pushing through your heels. Avoid arching your lower back.
4. Hold at the top for one to two seconds, then lower your hips back down to the ground.
Your goal should be to form a straight line from your knees to shoulders, ensuring no arching in the back. Beginners may not raise their hips very high at first, but with practice, they can aim for a perfect alignment.
The glute bridge can be incorporated into your workout routine as a warm-up or stand-alone exercise. Beginners should aim for 3–4 sets of 10–12 reps, focusing on proper form. Advanced trainees may use the glute bridge as a warm-up for heavier exercises, doing 30-second intervals with short rests. If you spend long hours sitting, try doing a few sets throughout the day to keep your posterior muscles engaged.
1. Squats: Classic and powerful, squats target your glutes, quads, and hamstrings. You can do bodyweight squats or add dumbbells/barbells for more intensity.
2. Lunges: Forward, reverse, and walking lunges are excellent for engaging the glutes while also improving balance and coordination.
3. Step-Ups: Using a bench or sturdy platform, step-ups activate the glutes, especially when you push through your heel on the working legs.
4. Deadlifts (especially Romanian or Single-Leg Deadlifts): These strengthen the glutes and hamstrings while also working your lower back and core.
5. Donkey Kicks: This bodyweight move isolates the glute muscles and is great for glute activation. You can add ankle weights or resistance bands for an extra challenge.
Credit: AP Photos
A 38-year-old US nurse practitioner has completed seven marathons while pregnant with her first child, raising questions about the safety of intense exercise during pregnancy.
Deirdre Keane, who works at Memorial Sloan Kettering Cancer Center, had completed more than 60 marathons before taking on the World Marathon Majors.
She discovered she was pregnant after noticing a slower pace during the Tokyo Marathon in March. After receiving clearance from her obstetrician-gynaecologist (OB-GYN), she decided to continue racing.
The World Marathon Majors include races in Tokyo, Boston, London, Sydney, Berlin, Chicago and New York.
Keane had initially signed up for 11 events, including seven major marathons, a trail marathon, two ultramarathons and an Ironman competition.
After discovering her pregnancy, she dropped the Ironman and one ultramarathon and agreed to take the Ireland marathon slowly.
She completed the New York City Marathon in just over four hours at 34 weeks of pregnancy, averaging 9 minutes and 26 seconds per mile, according to New York Road Runners. She had finished the same race in just over three hours in 2025.
"I knew how bizarre it was to be running a marathon at 34 weeks, but I also knew how fit I was and self-aware of my body at this point," Keane told The Associated Press.
Her doctor advised her to monitor her nutrition and hydration and stop exercising at the first sign of muscle cramping, according to the World Running Network.
"I want to teach my son resilience and that he can do hard things," she said.
Exercise is generally safe during an uncomplicated pregnancy. However, the intensity and type of activity matter.According to the American College of Obstetricians and Gynecologists (ACOG), women with healthy pregnancies can continue or begin regular physical activity after consulting their OB-GYN.
Women who regularly performed vigorous aerobic exercise before pregnancy may also be able to continue with medical approval.
However, research on prolonged, high-intensity activities such as marathon running during pregnancy remains limited.
ACOG recommends at least 150 minutes of moderate-intensity aerobic activity every week for pregnant women without medical or obstetric complications. Brisk walking and gardening are examples.
How Can Exercise Benefit The Mother And Baby?
Regular physical activity during pregnancy can:
However, these benefits do not mean strenuous exercise is suitable for every pregnant woman. Consult an OB-GYN before starting or continuing an intense workout routine.
ACOG recommends the following precautions:
Pregnant women should avoid activities that increase the risk of falls, abdominal injuries or overheating, including:
ACOG advises pregnant women to stop exercising and contact their OB-GYN if they experience:
Credit: AI-generated image
What happens when people stop taking GLP-1 weight-loss injections like Ozempic, Wegovy or Mounjaro? Do they regain weight, switch to another medication or consider bariatric surgery?
A new study published in The Lancet's eClinicalMedicine examined that what people do after their initial GLP-1 treatment can make a significant difference in their long-term weight outcomes.
Researchers at Cleveland Clinic examined health records from 20,486 patients who had taken semaglutide or tirzepatide injections for at least three months.
They compared five weight loss maintenance over a two-year period: continuing the original weight loss medication, switching between the two drugs, moving to another obesity medication, undergoing bariatric surgery or stopping treatment altogether without pursuing another option.
After two years, the average weight reductions were:
These results indicate that discontinuing GLP-1 treatment does not mean all the lost weight will come back. But patients who stopped treatment without another medical or surgical intervention experienced the lowest success in keeping the weight off.
The study also found that the outcomes of switching depended on which medication patients were taking initially. Those who moved from semaglutide to tirzepatide lost more weight than those who continued semaglutide. However, among people initially taking tirzepatide, remaining on the medication led to greater weight loss than switching to semaglutide.
Also read: Stopping Ozempic or Wegovy May Double Your Risk Of Heart Attack, Death
Not just weight loss, the findings also covered metabolic outcomes as patients with existing health conditions also showed significant differences.
Among participants with type 2 diabetes, bariatric surgery proved to drive major improvement in HbA1c. This was followed by switching between semaglutide and tirzepatide, continuing the original medication and moving to another obesity drug.
Patients with hypertension who continued treatment also experienced greater reductions in blood pressure than those who stopped.
Those who discontinued treatment without another intervention showed the smallest improvements in blood glucose control and blood pressure.
GLP-1 medications have become increasingly popular for managing diabetes and combating obesity, but long-term treatment can be difficult for some patients to maintain.
Cost, insurance and side effects are among the reasons why people may discontinue these medicines. Gastrointestinal symptoms like nausea, vomiting, diarrhoea and constipation can also affect adherence to treatment.
People who cannot continue their original medication, and are considering switching to another treatment or considering bariatric surgery should discuss their options with their healthcare providers.
Lead author Hamlet Gasoyan, a researcher at Cleveland Clinic's Center for Value-Based Care Research, said, “The encouraging news is that, for patients who need to stop their injectable GLP-1 medication, it does not mean that their obesity treatment journey has to end.”
Co-author Ali Aminian, director of Cleveland Clinic's Bariatric and Metabolic Institute, added, “When a patient stops a GLP-1 medication, the most important question is what comes next.”
He noted that patients who stopped all treatment had the least weight loss while those who moved on to another therapy, particularly bariatric surgery, did significantly better.
Credit: iStock
For years, body mass index (BMI) has been a key health marker to track obesity. But a recent study suggests that not everyone classified as obese based on their BMI may have obesity-related health problems. Researchers say just considering BMI alone may lead to incorrect diagnosis in some people while overlooking others with excess body fat and related health risks.
The international study, involving more than 844,000 adults across China, the UK, the US and Spain, supports a different approach that considers body fat distribution, waist measurement and the impact of excess fat on organ function.
Researchers propose distinguishing between two categories: pre-clinical obesity, in which excess body fat increases health risks but has not impaired organ function, and clinical obesity, in which excess fat is already affecting the body's ability to function.
BMI is calculated by dividing a person's weight in kilograms by their height in metres squared. It is used to classify people as underweight, normal weight, overweight or obese.
However, BMI does not directly measure body fat or show where fat is distributed. It also cannot distinguish between fat and muscle mass. Consequently, two people with the same BMI may have very different body compositions and health risks.
The researchers found that adding waist circumference and waist-to-height ratio to BMI helped identify people whose excess body fat might otherwise be missed.
The analysis suggested that BMI alone missed obesity level body fat in up to 8.6% of participants, while incorrectly classifying up to 3.1% as having obesity in the study groups.
Professor Francesco Rubino, senior author of the study and Chair of Metabolic and Bariatric Surgery at King's College London, said, “Body mass index alone cannot tell us whether someone is already ill or at risk of illness, or what care they need, leaving people vulnerable to both undertreatment and overtreatment.”
Also read: Loud Snoring Is Not Always Harmless: Sleep Apnoea can Become a Stroke-Risk Concern
The researchers used a framework proposed by the Lancet Diabetes and Endocrinology Commission in 2025. It separates obesity into two categories based on whether excess body fat has affected a person's health.
The study estimated that only around 23% to 31% of people classified as having obesity across the four study populations had clinical obesity. This represented approximately 5.6% to 10.9% of the overall adult populations studied.
The researchers followed participants over time to examine how often pre-clinical obesity progressed to clinical obesity.
They found that approximately 77% to 91% of people classified as having pre-clinical obesity did not progress to clinical obesity over 10 years. However, progression rates differed across the study populations.
Clinical obesity was linked with a higher risk of death while pre-clinical obesity had a more modest increase in risk.
Professor Rubino said, “Preclinical obesity should therefore be neither treated automatically as active disease nor dismissed as harmless. Some people may need preventive treatment, but its intensity should match their individual risk.”
The findings do not mean that people with pre-clinical obesity should ignore excess body fat. Rather, they highlight the importance of assessing individual health risks instead of making treatment decisions based on BMI alone.
People with excess body fat may still benefit from lifestyle hanges, treatment and preventive care even if they have not developed organ dysfunction.
© $2026 Times Horizon Private Limited